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Abstract  
Polymeric stent is a temporary cardiovascular scaffold, made of biodegradable poly (l-lactic) acid, 
to treat coronary artery stenosis, with expected resorption by the human body over two to three 
years. In this paper, the mechanical properties of a polymeric stent over two-year in vitro 
degradation were studied and characterised using atomic force microscopy and nanoindentation 
techniques, complemented with analyses of weight loss, gel permeation chromatography and 
differential scanning calorimetry. Atomic force microscopy assessed stent degradation at the 
surface, whilst nanoindentation was able to investigate the property at a greater depth into the 
material. No significant changes to the Young’s modulus were observed with the atomic force 
microscopy due to bulk degradation nature of the polymer. Chemical analyses demonstrated a 
reduction of molecular weight and an increase of crystallinity, indicating degradation of the stents. 
Berkovich nanoindentation showed a trend of reduction in modulus over in vitro degradation, 
which was, however, not continuous due to the variations of measurements associated with the 
pyramidal indenter tip and the semi-crystalline structure of the polymer. 
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1. Introduction 
Biodegradable polymers are used for a range of medical devices, including sutures and implantable 
scaffolds [1]. Polylactides is a common polymer group used extensively in these applications. The 
chiral nature of polylactides (polyester) results in multiple structural forms of the molecule, with 
poly (L-lactic acid) (PLLA) shown to be the most promising for stent applications [2-5]. PLLA has 
an intrinsic degradation property, and the material can be broken down, excreted or resorbed by 
the metabolic pathways within the body without surgical intervention [1]. Here, degradation is 
defined as the chain scission process, during which polymer chains are cleaved to form oligomers 
and monomers [6]. Due to hydrolysable bonds within the polymer, there are two possible means 
of chain cessation, i.e., chemical degradation via hydrolysis or enzyme catalysed hydrolysis, with 
the former being more prominent for the degradation of bioresorbable stents [7, 8].  
 
Degradation of PLLA has been studied in various forms, encompassing fibers, thin films and bulk 
specimens. Yuan et al. [9] assessed in vitro degradation of PLLA fibers incubated in phosphate 
buffer solution (PBS) at 7.4 pH level and 37oC for up to 45 weeks. Three kinds of fibers with 
varying diameters and molecular weights were investigated. It was shown that their average 
molecular weight decreased progressively with degradation, with a drop of 39.3% - 57.9% for the 
three fiber sets. Despite this molecular weight regression, corresponding decrease in respective 
masses was not observed for any of the fiber sets. An increase in crystallinity was demonstrated 
with differential scanning calorimetry (DSC), which corresponded to an increase in molecular 
order of polymeric chains in semi-crystalline structures. Tensile properties were also assessed for 
these fibers; however, there were no significant changes after 35 weeks of in vitro degradation for 
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thicker strands. Thinner fiber strands showed a decrease in ultimate strength with respect to initial 
values. Nuutinen et al. [10] assessed the mechanical properties and in vitro degradation of PLLA 
bioresorbable knitted stents, constructed using single self-reinforced fibers. The in vitro degradation 
of the PLLA fibers showed a decline in ultimate tensile strength, with a decrease from ~300 MPa 
to 0 MPa over the course of 35 weeks. Similar to the work of Yuan et al.9, the molecular weight of 
the PLLA fibers diminished over a 50-week period but 90% of its mass was retained over the same 
time period. Even after 110 weeks of in vitro degradation, the PLLA scaffold maintained 59% of 
its mass. Zilberman et al. [11] investigated the mechanical properties and in vitro degradation of 
PLLA bioresorbable fibers, which showed excellent biocompatibility and high tensile mechanical 
properties (a tensile strength of 967 MPa and a modulus of 5 GPa). During the 6-week in vitro 
degradation, PLLA showed no weight loss while tensile testing of the fibers exhibited a 30.1% and 
8.9% drop in tensile strength and modulus, respectively.  
 
In addition, Jowsa et al. [12] discussed how changes within the core of a biodegradable polymer 
can be attributed to its amorphous fraction which is capable of absorbing more water, therefore 
affecting degradation and material properties. In their study, PLLA was produced by injection 
moulding. The reduction in strength was less than 10% after a five-month incubation period, 
proving advantageous for supporting vessel wall regeneration. Luo et al. [13] tested the behaviour 
of polymeric stents, made of ultra-high-molecular-weight PLLA, both in vitro and in vivo. For in 
vitro study, the stents were integrated into a customary system, consisting of a plasma pump and a 
mock artery loop, to simulate the in vivo environment. Flow pressure applied was equal to that of 
the human circulatory system, with the temperature and pH level of the system regularly 
monitored. For assessment of in vivo degradation, stents were implanted into pig arteries of similar 
dimensions to the mock arteries. The degradation of stents was assessed under both in vitro and in 
vivo conditions, showing good agreement with each other in terms of the change of stent outer 
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diameter and the reduction of molecular weight at 1, 3 and 6 months; however, there was no 
information on the rate or characteristics of stent degradation. 
 
PLLA used in the biomedical field is usually tailored for a specific application, and therefore, results 
presented in literature are specific for the materials studied and cannot be generalised. This is due 
to different processing, manufacturing and sterilization conditions which affect material properties 
as a result of the variation in crystallinity [14]. Ghosh et al. [15] demonstrated that melt processing 
of polymers can degrade the material and therefore, change its properties. Also, existing work is 
largely limited to the polymer fibers or bulk samples, and there is a lack of study regarding the 
degradation of polymeric stents in their manufactured states, especially the change of material 
properties over degradation. In this paper, properties of PLLA biodegradable stent were assessed 
over degradation under in vitro conditions. Efforts were made to assess the local properties of 
polymeric stent, at different length scales (200 nm to 4 m), in manufactured states. The work 
covers assessment of its surface properties via profilometry and indentation studies at different 
depths. Both atomic force microscopy (AFM; 200 nm) and nanoindentation (up to 4 m) were 
carried out to assess the material properties over two-year in vitro degradation. The work was 
complemented with chemical analyses to quantify the molecular-weight loss and crystallinity 
variation over the degradation process.  
 
2. Experiments 
2.1 Material and samples  
The samples for the in vitro degradation study were poly-lactic acid (PLLA) stent (Fig. 1a) supplied 
by Abbott Vascular (California, USA). The wall thickness for the stent is ~150 µm and the strut 
width is ~200 µm, confirmed also with optical imaging (SmartScope Flash 200). Stent sections 
containing 3-4 rings were produced using a sharp blade in a sterile environment and incubated in 
glass vials containing phosphate buffer solution (PBS) at 37oC (Fig. 1b). PBS was changed monthly 
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to maintain a neutral pH level (~7.4) throughout incubation. This was determined after carrying 
out a pre-testing study (i.e., a set of simple tests to determine if the pH level would change with 
incubation time), which found insignificant pH changes over one-month period. Indicator sticks 
(Fisher brand) were also used to monitor pH level over the duration of the study to guarantee 
neutrality. Assessment of stent rings was carried out at monthly intervals.  
 
 
 
Figure 1, (a) Polymer stent and (b) ring section in a vial filled with PBS. 
 
2.2 Surface Profilometry 
Roughness measurements were carried out using a ContourGT-X 3D optical profilometer 
(Bruker, U.S.A) to assess the surface topography. These non-contact surface measurements and 
characterisation of surface features were carried out for samples in virgin and degraded states. In 
particular, the arithmetic average of absolute values of height deviations from a mean line, i.e., Ra, 
was evaluated over a desired length. In this study, five measurements were taken randomly across 
the outer surfaces of the stent. Data was analysed using the Vision64 Map Software and 
MountainsMap Universal (Digital Surf).  
 
2.3 Atomic Force Microscopy (AFM)  
Surface indentations were carried out using an AFM Explorer (Veeco), with indents made on three 
locations across the stent, i.e., a tri-junction, a straight strut and a U-bend (Fig. 2). 20 indents were 
3 mm 
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made at each location randomly using a silicon tip with a radius of 10 nm. A 10 nN load was set, 
and the corresponding displacement was recorded during loading and unloading. A 200 nm offset 
was applied to counteract the effect of any possible contamination, which might be present on the 
sample surface. Indents were made on surfaces normal to both the radial and longitudinal axes of 
the stent to assess variability in these two directions. Using a method proposed by Tang et al. [16], 
the elastic modulus of the material was calculated on the basis of Sneddon’s elastic contact 
solution: 
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where Er is the reduced modulus of the material related to the contact between the tip and the 
sample, E and ν are elastic modulus and Poisson’s ratio of the material, Ei and νi are the elastic 
modulus and the Poisson’s ratio of the indenter tip (137 GPa and 0.17, respectively [16]). The two 
parameters 𝛼 and A define the cantilever-tip property and cantilever sensitivity, respectively. They 
were obtained through carrying out AFM tests on two reference materials with the known moduli. 
Here, poly (methyl methacrylate) (PMMA) and polystyrene (PS) were considered with a modulus 
of 2.76 GPa and 3.55 GPa, respectively, which were obtained using dynamic mechanical analysis 
(DMA).  The parameter K was defined as the gradient of the unloading curve obtained with AFM. 
Once these values are known, they can be used to quantify the unknown elastic modulus of a 
material using equation (2). The assumption is made that no plastic deformation of the tip occurs 
during this calibration procedure [16]. Stent rings were mounted onto metallic rod, which exactly 
fit the inner area of the stent to ensure support of the stent during indentation. 
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Figure 2, Images and schematic of the areas of interest across the stent. 
 
2.4 Nanoindentation 
Nanoindentation was performed using a Platform 3 indenter (Micromaterials, Wrexham). This was 
carried out on a nanoscale using a Berkovich tip. A loading rate of 0.5 mN/s and an unloading 
rate of 5 mN/s were chosen, with a 40-second dwell time at the level of maximum loading. To 
allow for correction of indentation data with regard to thermal drift, a hold phase of 60 s was 
implemented at 80% of unloading. The elastic modulus of the materials was determined using the 
Oliver-Pharr theory, based on the slope of the unloading curve (top portion; 20%) [17]. Using 
equation (2), the elastic modulus of the material can be calculated with the knowledge of the 
reduced modulus. Here, the values of Ei and νi were 1140 GPa and 0.07 for a diamond indenter 
tip [18]. 
 
2.5 Weight Loss 
Weight loss of samples was assessed against the incubation time in PBS. Measurements were taken 
using an Ultra-Micro balance (Sartorius SE2). Measurements of all samples were taken before their 
incubation and after the samples had been dried in an oven (37oC; below the polymer glass 
transition temperature) for 48 hours to remove moisture. The weight loss was then calculated as a 
percentage using the following equation: 
 
𝑊𝑒𝑖𝑔ℎ𝑡 𝑙𝑜𝑠𝑠 (%)  = ஼௛௔௡௚௘ ௜௡ ௪௘௜௚௛௧
ை௥௜௚௜௡௔௟ ௪௘௜௚௛
  100%.      (3) 
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2.6 Gel Permeation Chromatography (GPC)  
GPC, also referred to size exclusion chromatography (SEC), allows for size-based separation of 
molecules in solution. GPC was used to assess the changes in molecular weight of the structure 
with degradation time. The ring section of Absorb stent was dissolved in the eluent at a 
concentration of 1 mg/ml. A 100 µl injection volume was used for each sample. It was ensured 
that the ring sections were fully dissolved prior to injection onto the column. GPC measurements 
were obtained in CHCl3 + 2% triethylamine (TEA) at a flow rate of 1 mL/min, on a set of two 
PLgel 5 µm Mixed C columns plus a guard column, using a refractive index detector. Both the RI 
detector and columns were held at 40°C. Cirrus SEC software was used to analyse the data using 
polystyrene (PS-M) standards. 
 
2.7 Differential Scanning Calorimetry (DSC) 
DSC is acknowledged as the preferred technique to understand the thermodynamic changes in a 
polymer. This process assesses the apparent molar heat capacity of a macromolecule as a function 
of temperature. Through manipulation of temperature, a whole visualization of the 
thermodynamic character of the material can be obtained [19]. Here, rings were sectioned from 
the whole stent, with a mass of 2.9240 mg, for testing in a DSC system (Universal V4, TA 
instruments). 
 
3. Results  
3.1 Surface Profilometry  
Surface profilometry was used to assess the surface properties of polymeric stent after 
manufacturing as well as at different stages of the in vitro degradation process. Fig. 3a illustrates the 
stent surface captured, where the black regions are redundant space. The redundant region, along 
with surface curvature, was subsequently removed to produce an area which can then be analysed 
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in two directions of interest, i.e., west to east (i.e., direction 1) and north to south (i.e., direction 2) 
as shown in Fig. 3b.  The assessed area was then converted into a series of profiles so that an 
average surface roughness of the sample was obtained in comparison to a solo profile reading. Fig. 
3c shows the series of profiles for the assessed area, with the average profile highlighted in blue. 
Three random areas of the stent surface were investigated with a size of 200×200 μm2, from which 
averages were taken (Table 1). 
 
 
 
Figure 3, (a) Stent area scanned with optical profilometer, (b) surface area after removal of 
outlying area, and (c) typical series of profiles for the assessed area. 
Table 1, Roughness data for stent surface (E  W = East to west; N  S = North to south) 
Month Direction Average Ra S.D. 
0 W  E 0.155 0.0376 
0 N  S 0.154 0.0508 
12 W  E 21.1 4.68 
100 µm 
50 µm 
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12 N  S 21 4.75 
18 W  E 18.4 5.21 
18 N  S 12.3 2.65 
24 W  E 8.26 3.53 
24 N  S 9.45 1.26 
 
From Table 1, it can be ascertained that the roughness of the stent in both directions remains 
consistent. The stent initially had a very low surface roughness, as a result of manufacturing 
process. With increasing degradation time, there is an observed increase in surface roughness at 
month 12 and then declining between month 12 and 24 as shown in Fig. 4. Although the roughness 
peaks at 12 months, it is not expected to affect the device performance as, by this time point, the 
stent is fully integrated into the vessel wall. When assessing the optical images of the stent between 
month 0 and 24 (Fig. 5), there seems no obvious visual evidence of surface erosion. 
 
 
 Figure 4, Evolution of surface roughness for the stent with degradation. 
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Figure 5, Optical images of stent surface of (a) virgin, (b) 12-month, (c) 18-month and (d) 24-
month samples. 
3.2 Weight Loss and Chemical Analyses 
3.2.1 Weight loss  
The weight loss is indicative of the loss of smaller polymer sections formed due to chain scission, 
leaving behind the core of the material. This is a feature of bulk degradation, which the aliphatic 
polyesters, such as PLLA, normally undergo [20]. Fig. 6 shows the percentage of weight loss for 
the samples (Equation (3)). Before measurements, drying process was carried out at a temperature 
(37ºC) below the glass transition temperature Tg, therefore not affecting the material by additional 
thermal degradation. Only one sample was measured for each month due to the limited amount 
of tubing and stents available for this study. The results obtained in this study concur with bulk 
degradation in polymers, due to the extremely limited amount of weight loss. This could even be 
construed as negligible, as weight loss remained below 2% of the sample’s initial weight. These 
results agree with multiple studies [21-24], where no significant weight changes were found for 
(b) (a) 
(c) (d) 
50 m 
50 m 20 m 
100 m 
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solid PLLA with in vitro degradation during a substantial portion of the time scale expected for full 
resorption of the device within the body. 
 
Figure 6, Weight loss with degradation over a 2-year period. 
 
3.2.2 Molecular weight change 
Fig. 7 illustrates the GPC curves at 0, 12, 15 and 18 months. Data presented here correspond to 
elution of the polymer between approximately 10 and 16 minutes. A change in the chemical 
composition is manifested as a shift to a later elution time and a larger peak for the degraded 
samples. Later elution corresponds to the presence of molecules with a reduced chain length and 
molecular weight, which is anticipated due to chain scission during degradation. This is 
corroborated with the data presented in Table 2, where the molecular weight of the highest peak 
drops drastically from 0 to 21 months (by 65%) and the molecular weight (Mn and Mw) also 
depletes. The polydispersity index, which is used as a measure of the breadth of the molecular 
weight distribution and defined as Mw/Mn [25], remained almost constant over the course of two 
years of in vitro degradation. Concentration of the samples was consistent across all testing. It can 
be said with certainty here that there was degradation taking place due to the decline in molecular 
weight of the material [24]. 
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Figure 7, Effect of degradation on raw molecular weight detected by GPC. 
 
 
 
Figure 8, Standard plot of log Mw with elution time. 
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Table 2, Data obtained from the GPC analyses with molecular weight normalised to that at 
virgin state (month 0). 
Month 0 12 15 18 21 
Normalised molecular weight 
at the peak (Mp) 
1.0 0.55 0.38 0.36 0.35 
Normalised number average 
molecular weight (Mn) 
1.0 0.66 0.49 0.42 0.41 
Normalised weight average 
molecular weight (Mw) 
1.0 0.65 0.48 0.43 0.41 
Polydispersity index (PD) 2.00 1.97 1.97 2.04 2.01 
 
The logarithm of molecular weight against the elution time is plotted in Fig. 8, where a typical 
linear trend is seen at both time points. These results agree with those in Fig. 7, where products of 
degradation are present due to the shift in elution time, corresponding to lower molecular weight 
chains. There are 3 stages of degradation for aliphatic polyester polymers which undergo bulk 
hydrolytic degradation: (1) second order hydrolysis, (2) auto-acceleration and (3) dissolution of 
degradation products [22]. For the period over which the stent was exposed to in vitro conditions, 
it seems that the specimen was in either of the first 2 stages of degradation as there was no obvious 
weight loss. This correlates well with the results for molecular weight. Basically, although there 
was no obvious weight loss, there was an obvious decline in molecular weight of the PLLA chains. 
This confirms that degradation and chain scission are occurring; however, the smaller chains are 
not able to diffuse out of the sample, therefore explaining the negligible weight loss. 
 
3.2.3 Crystallinity variation 
As established in previous work, DSC is a preferred technique to assess thermodynamic changes 
in a polymer. Here the procedure was conducted to assess the thermal properties of the degraded 
samples and ultimately their crystallinity percentage over in vitro degradation. As seen in Table 3, 
from the beginning to the end of the degradation period (2 years), the sample crystallinity increased 
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by 25.9%, which corresponds to the bulk degradation mechanism for aliphatic polyesters such as 
PLLA. Basically, the amorphous regions are the first to succumb to attack by hydrolytic 
degradation, thereby increasing the sample crystallinity with degradation time [23, 24]. Based on 
the continual increase in sample crystallinity over the 2-year period, it can be said that degradation 
was in the mid-phase for these in vitro samples, as its decline in crystallinity would be expected after 
the peak when the shorter polymer chains start to move out of the sample. Overall, the results 
from DSC, GPC and weight loss analyses agree with one another. It should be noted that the 
samples were not dried in vacuum, which could give an overestimation of crystallinity due to the 
occurrence of oxidation in the drying process. 
 
 
 
 
Table 3, DSC data for degraded samples 
Sample (months) Enthalpy of melt (J/g) Crystallinity (%) 
0 52.68 56.66 
12 70.7 76.02 
18 77.01 82.87 
24 79.57 82.56 
 
3.3 Mechanical Characterisation 
3.3.1 AFM measurements 
AFM allows for interrogation of a sample surface at shallow indentation depths. Tang et al. [16] 
proposed a method to quantitatively measure the elastic modulus of a material using AFM, where 
the unloading portion of the load-displacement curve was used to assess the modulus (Section 
2.3). Figs. 9a-c shows the unloading curves obtained with AFM for samples which underwent 
degradation for 18 months. Results are presented at a 6-month interval. The results here suggested 
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that there was no significant difference in material response between the three locations of interest, 
confirming the consistency of the surface layers of the sample (up to 200 nm according to AFM).   
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Figure 9, AFM results at 3 different locations with degradation 
Fig. 10 shows the average elastic modulus, with error bars, for each sample, and provides a 
representation of the surface layer behaviour, due to the shallow 200 nm indentation depth, over 
in vitro degradation times. There appears to be no dramatic changes to the modulus over time, 
which is as expected due to the prolonged degradation life that PLLA presents in vitro. These results 
back up those of weight loss, as there is no reduction in the weight and the samples still possessed 
material integrity. Additionally, this is concurrent with the degradation mechanism of PLLA, i.e., 
bulk degradation taking place while the surface layers of the material remain intact.  
 
 
Figure 10, Evolution of surface elastic modulus over two-year in vitro degradation 
 
The values presented in Table 4 are an average of 20 indents, which were taken at random locations 
over each area. The modulus over the two-year period changed in a range between 1.70 and 2.28 
GPa, with a fluctuation of 0.5 GPa. On closer inspection of Fig. 10, the modulus values were not 
constant. The irregular pattern could be assigned to numerous factors. AFM measures properties 
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on a nanoscale, while polymer chains are generally on an angstrom scale. As a result of this size 
mismatch, the variation in both standard deviation and modulus over time was due to spatial non-
uniformity of the molecular structure. As illustrated in Fig. 11, it is possible for indents to be made 
in a single-phase area of the polymer, i.e., amorphous, crystalline or spherulite region. The work 
by Iqbal et al. [26] showed that it is possible that indentation at a crystalline polymer chain could 
yield mechanical properties significantly different from indentation at amorphous area, which is 
referred as the bi-modal response of polymers. 
 
Table 4, Average Young’s modulus values (GPa) of 20 indents for each location. 
Month U-bend Tri-junction Straight strut 
0 1.93 2.24 2.11 
3 1.92 2.00 1.92 
4 1.80 1.89 1.91 
5 1.91 1.88 1.92 
6 1.77 1.76 1.70 
7 1.87 1.86 1.86 
8 1.76 1.74 1.77 
9 2.17 2.22 2.23 
12 2.08 2.09 2.09 
14 2.13 2.21 2.11 
15 1.97 2.03 2.01 
17 2.28 2.28 2.26 
18 1.87 2.13 2.28 
19 1.95 2.23 2.26 
20 2.21 2.17 2.12 
21 2.06 1.85 2.15 
22 1.98 2.06 1.95 
23 2.04 2.04 1.97 
24 1.85 1.92 1.93 
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Figure 11, Schematic of AFM indentation into a semi-crystalline material, where it is possible to 
indent different regions.  
 
3.3.2 Nanoindentation measurements 
Nanoindentation allows for assessment of material properties at depths greater than AFM, aiming 
to ascertain changes in mechanical properties of the material over degradation at a larger scale. 
Initially, a range of depths were investigated by varying the load used for indentation with a 
Berkovich indenter in order to select the ideal parameters for main experiments. Fig. 12 illustrates 
the force-displacement curves, with differing indentation loads, for an 18-month sample. There 
are no similar trends for loading or unloading curves with each indent. This is particularly 
significant for the unloading curve as its top portion is used to calculate the Young’s modulus of 
the material using the Oliver-Pharr theory. Table 5 compares the data for 4 indents which were 
carried out on the same 18-month sample using the same testing set up. Here we can see the wide 
variation of mechanical properties, with a difference of 1.45 GPa between the largest and the 
smallest Young’s modulus values obtained from indentation in a small region. What should be 
noted here additionally is that these results were produced at the same load, but with drastically 
different maximum indentation depths. As discussed for AFM (Fig. 11), indentation is generally 
specific to areas within the polymer. For nanoindentation, a sharp tip such as the three-sided 
Berkovich tip can cause an internal shift of polymer chains, leading to such obscure results. 
Crystalline region 
Amorphous region 
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Increase in chain mobility as a result of the shortening of polymer chains, due to their scission 
with degradation, would be a reason for result inconsistency. The shorter chains could also cause 
the increase in material elasticity seen with degradation. Another factor could be a gradient of 
mechanical properties through the cross section of the stent, linked with bulk degradation and/or 
manufacturing process. 
 
Figure 12, Illustration of variation in curves with varying loads for an 18-month sample 
 
Table 5, Data comparison for indentation made on the sample at four different locations under 
the same load (23 mN). 
Max. 
depth 
(nm) 
Residual 
depth 
(nm) 
Plastic 
deformation 
(%) 
Hardness 
(GPa) 
Reduced 
modulus 
Er(GPa) 
Young’s 
modulus 
E (GPa) 
Contact 
compliance 
(nm/mN) 
3482.9 3109.4 89.28 0.097 2.66 2.32 21.65 
2246.2 1922.2 85.57 0.254 4.96 4.33 18.78 
3868.1 2694.5 69.66 0.129 0.98 0.85 68.04 
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3921.8 2825.1 72.03 0.118 1.00 0.87 63.58 
 
Fig. 13 shows the span of the modulus which were obtained from indentation between 10 mN 
and 23 mN on the stent ring samples. There is a large variation in the results due to the two-phase 
structure of PLLA, as illustrated in Fig. 11. As discussed in Section 3.3.1 for AFM, it is possible 
for indents to be made in a single-phase area of the polymer, i.e., amorphous, crystalline or 
spherulite region. Indentation at a crystalline polymer chain could yield mechanical properties 
significantly different from indentation at amorphous area [26]. Overall, a decline can be seen in 
the modulus from month 0 to month 15, followed by an increase at month 18 and a continued 
decline afterwards. As discussed above (Table 3), differential scanning calorimetry yielded a 
crystallinity of 82.27% at Month 18, and there is an 82.27% chance of indenting in crystalline 
region, resulting in higher Young’s modulus. Factors such as sample preparation and the variation 
of rings used for indentation may further increased this chance. Overall, the results could be seen 
as a trend of degradation; however, at this point, further investigation is currently ongoing to draw 
a definitive conclusion, especially by exploring an alternative spherical nanoindentation technique 
which may overcome the issues related with the bimodal structure of PLLA. Furthermore, the 
moduli for all the samples, obtained at various degradation times, are presented in Fig. 14 against 
the plastic deformation which was calculated as (residual depth/maximum depth)×100%. A 
pattern is observed for all the samples, where the obtained moduli sit in one of the two regions, 
corresponding to either amorphous or crystalline structure of the material.  
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Figure 13, Data obtained for indentation on each sample during degradation. 
 
Figure 14, Young’s modulus vs. material plasticity at different degradation times. 
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4. Discussions 
To the best of our knowledge, nanoindentation was not used previously to assess the mechanical 
properties of polymeric stent rings. It can be deduced that pyramidal indentation of polymeric 
materials makes it a challenge to interpret the change of the material properties over in vitro 
degradation. Even at consistent loads, different penetration depths into the material were reached, 
therefore yielding different mechanical properties. As shown in Table 5, the penetration depth 
varied between 2.2 m and 3.9 m under under a 23 mN load, resulting in different modulus 
values. Shallower indents align with higher elastic modulus and deeper indents deliver lower 
modulus, which could be a signature of indentation size effect (ISE), intrinsic behaviour of 
materials under nanoindentation. When assessing nanoindentation as a method for capturing the 
degradation of PLLA stents, it can be concluded that this is a localized method of analysis and 
largely affected by the semi-crystalline structure of the material. The variability of degradation 
results obtained from pyramidal indentation can also be attributed to the material’s non-
homogenous properties across the whole stent, related to the manufacturing process. Taking all 
these considerations into account, quantification of degradation effects on stent mechanical 
properties cannot be made solely with pyramidal nanoindentation. So, effects of material 
degradation, non-uniformity of the polymer chain alignment and testing methodology (i.e., ISE) 
cannot be separated in this case, and consequently, additional techniques such as spherical 
nanoindentation and/or structural testing [27] need to be sought in order to deliver more 
consistent measurements of the material properties over degradation.  
 
In this study, multiple indents were randomly taken across the sample surface to obtain a large 
data set. For the values of modulus, standard deviations were calculated to quantify the amount of 
dispersion of the data obtained, for both AFM and nanoindentaion. This has been provided in 
Tables 6 to 9. Each table lists the mean and maximum/minimum values of the measurements at 
different degradation times, with the values of standard deviation (SD). It can be seen that AFM 
24 
 
measurements (Tables 6 to 8) gave less variations than nanoindentation measurements (Table 9), 
as also reflected in Figs. 10 and 13. As discussed above, this is associated with the difference in 
penetration depths for the two methods as well as the bulk degradation nature of PLLA. 
 
Table 6, Statistical data for modulus obtained with AFM for straight strut. 
Straight 0 3 6 9 12 15 18 20 22 24 
Min 2.00 1.80 1.67 2.06 2.06 1.93 2.05 1.97 1.84 1.88 
Max 2.21 2.34 1.73 2.27 2.11 2.06 2.85 2.30 2.00 1.94 
Mean 2.106 1.915 1.700 2.225 2.086 2.015 2.276 2.12 1.951 1.920 
SD 0.084 0.116 0.024 0.098 0.019 0.050 0.292 0.131 0.056 0.022 
 
 
Table 7, Statistical data for modulus obtained with AFM for U-bend strut. 
U-bend 0 3 6 9 12 15 18 20 22 24 
Min 1.81 1.76 1.72 2.09 2.03 1.95 1.79 2.19 1.98 1.55 
Max 1.96 2.01 1.79 2.2 2.12 1.98 2.22 2.22 2.02 1.93 
Mean 1.932 1.922 1.773 2.168 2.078 1.974 1.873 2.21 1.98 1.846 
SD 0.036 0.099 0.028 0.044 0.001 0.011 0.596 0.001 0.039 0.140 
 
 
Table 8, Statistical data for modulus obtained with AFM for tri-junction strut. 
Junction 0 3 6 9 12 15 18 20 22 24 
Min 2.07 1.86 1.68 2.12 2.05 1.94 2.23 2.03 1.93 1.88 
Max 2.40 2.06 1.82 2.29 2.1 2.12 2.87 2.25 2.18 1.95 
Mean 2.238 2.003 1.759 2.224 2.087 2.025 2.127 2.17 2.058 1.920 
SD 0.121 0.084 0.047 0.066 0.015 0.069 0.127 0.073 0.093 0.022 
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Table 9, Statistical data for modulus obtained with nanoindentation (stent ring). 
Month 0 3 6 9 12 15 18 21 24 
Min 0.007 0.086 0.116 0.521 0.047 0.039 0.0004 0.111 0.057 
Max 8.601 5.401 7.000 2.031 1.465 0.244 5.442 0.667 0.537 
Mean 3.698 3.431 1.995 1.801 0.300 0.213 2.356 0.249 0.265 
SD 2.844 2.076 1.790 0.757 0.301 0.077 1.507 0.126 0.134 
 
Biosafety, both chemical and mechanical, is of primary importance for medical stents. Chemical 
safety is largely dependent on the choice of materials. The bioresorbable stent studied in this paper 
is made of PLLA which is biocompatible, non-toxic and unlikely to induce severe inflammation 
to the vessel [28]. Also, their degradation products are natural and can be cleared out of the human 
body safely. Mechanical damage is normally caused by the stenting process as high pressure is 
required to expand the stent inside the diseased artery via balloon inflation. This can impose severe 
deformation to vascular wall, resulting in mechanical damage of artery layers [29]. To improve 
biosafety, it is important to control bioresorption at a desirable and predictable rate, which can be 
achieved by tuning molecular weight, crystallinity and hydrophilicity of those polymers [30]. In 
addition, mechanical damage can be minimised by optimising the stent structure and altering the 
material properties, based on computational and experimental techniques [28, 29]. In this work, 
we are more focused on the chemical and mechanical degradation behaviours of a commercial 
PLLA stent over two-year in vitro conditions, and the results can be used to support the design and 
optimisation of future bioresorbable stents to improve the biosafety. It should be noted that a 
proper biosafety study will require different methodologies and techniques, which is beyond the 
scope of current study.  
 
Recently, several independent clinical trials have raised the thrombosis issue associated with the 
long-term outcome (three years and beyond) of bioresorbable polymeric stents [31-34]. The exact 
cause of the problem has not been identified yet, but stent design and material are believed to play 
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important roles in the long-term performance of bioresorbable polymeric stents. As reported in 
Yamaji et al. [32], strut discontinuity caused by the loss of structural integrity during stent 
degradation was the leading mechanism of very late thrombosis for bioresorbable polymeric stents. 
In this case, one potential way to reduce the risk of thrombosis and debris shedding is to tailor the 
degradation rate, as well as control the change of mechanical properties, of bioresorbable 
polymeric stents through novel material processing and optimal structural design, with validation 
against thorough animal studies. Again, this will require a significant amount of additional effort 
and time, and is beyond the scope of current study. 
 
5. Conclusions 
In this paper, the mechanical properties of polymeric stent were assessed at nanoscale, on the 
surface as well as at a depth into the sample, which was not performed previously. The aim here 
was to assess the mechanical property change of the stent over degradation in manufactured states. 
No significant changes to the Young’s modulus were observed with AFM due to bulk degradation 
nature of the polymer. It was also established that pyramidal indentation provided a range of 
modulus values for the material, with lower modulus values related to the amorphous areas of the 
stent while higher elastic modulus resulted from indentations made in the crystalline regions. There 
was a trend of reduction in modulus with in vitro degradation, but not continuous due to the 
limitation of pyramidal indentation in testing semi-crystalline polymers. GPC analyses showed an 
over 2-fold decrease in molecular weight after 21 months of in vitro degradation, despite of 
negligible weight loss. These results indicated the bulk-degradation mechanism in PLLA, without 
significant mass loss during the stages of degradation studied in this paper. 
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